BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28956620)

  • 1. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.
    Taylor JH; Lebowitz ER; Jakubovski E; Coughlin CG; Silverman WK; Bloch MH
    J Clin Child Adolesc Psychol; 2018; 47(2):266-281. PubMed ID: 28956620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
    Compton SN; Peris TS; Almirall D; Birmaher B; Sherrill J; Kendall PC; March JS; Gosch EA; Ginsburg GS; Rynn MA; Piacentini JC; McCracken JT; Keeton CP; Suveg CM; Aschenbrand SG; Sakolsky D; Iyengar S; Walkup JT; Albano AM
    J Consult Clin Psychol; 2014 Apr; 82(2):212-24. PubMed ID: 24417601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
    Ginsburg GS; Kendall PC; Sakolsky D; Compton SN; Piacentini J; Albano AM; Walkup JT; Sherrill J; Coffey KA; Rynn MA; Keeton CP; McCracken JT; Bergman L; Iyengar S; Birmaher B; March J
    J Consult Clin Psychol; 2011 Dec; 79(6):806-13. PubMed ID: 22122292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
    Halldorsdottir T; Ollendick TH; Ginsburg G; Sherrill J; Kendall PC; Walkup J; Sakolsky DJ; Piacentini J
    J Clin Child Adolesc Psychol; 2015; 44(6):985-91. PubMed ID: 25310142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED).
    Caporino NE; Sakolsky D; Brodman DM; McGuire JF; Piacentini J; Peris TS; Ginsburg GS; Walkup JT; Iyengar S; Kendall PC; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):696-702. PubMed ID: 28735699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes.
    Ginsburg GS; Becker-Haimes EM; Keeton C; Kendall PC; Iyengar S; Sakolsky D; Albano AM; Peris T; Compton SN; Piacentini J
    J Am Acad Child Adolesc Psychiatry; 2018 Jul; 57(7):471-480. PubMed ID: 29960692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.
    Caporino NE; Brodman DM; Kendall PC; Albano AM; Sherrill J; Piacentini J; Sakolsky D; Birmaher B; Compton SN; Ginsburg G; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2013 Jan; 52(1):57-67. PubMed ID: 23265634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Strawn JR; Mills JA; Rothenberg R; Piacentini J; Peris TS; McCracken JT; Walkup JT
    J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36479955
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
    Strawn JR; Dobson ET; Mills JA; Cornwall GJ; Sakolsky D; Birmaher B; Compton SN; Piacentini J; McCracken JT; Ginsburg GS; Kendall PC; Walkup JT; Albano AM; Rynn MA
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):501-508. PubMed ID: 28384010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental psychopathology and treatment outcome for anxious youth: roles of family functioning and caregiver strain.
    Schleider JL; Ginsburg GS; Keeton CP; Weisz JR; Birmaher B; Kendall PC; Piacentini J; Sherrill J; Walkup JT
    J Consult Clin Psychol; 2015 Feb; 83(1):213-24. PubMed ID: 25222799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.
    Kendall PC; Cummings CM; Villabø MA; Narayanan MK; Treadwell K; Birmaher B; Compton S; Piacentini J; Sherrill J; Walkup J; Gosch E; Keeton C; Ginsburg G; Suveg C; Albano AM
    J Consult Clin Psychol; 2016 Jan; 84(1):1-14. PubMed ID: 26460572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturalistic follow-up of youths treated for pediatric anxiety disorders.
    Ginsburg GS; Becker EM; Keeton CP; Sakolsky D; Piacentini J; Albano AM; Compton SN; Iyengar S; Sullivan K; Caporino N; Peris T; Birmaher B; Rynn M; March J; Kendall PC
    JAMA Psychiatry; 2014 Mar; 71(3):310-8. PubMed ID: 24477837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of child-focused anxiety treatments for parents and family functioning.
    Keeton CP; Ginsburg GS; Drake KL; Sakolsky D; Kendall PC; Birmaher B; Albano AM; March JS; Rynn M; Piacentini J; Walkup JT
    Depress Anxiety; 2013 Sep; 30(9):865-72. PubMed ID: 23390005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes.
    Swan AJ; Kendall PC; Olino T; Ginsburg G; Keeton C; Compton S; Piacentini J; Peris T; Sakolsky D; Birmaher B; Albano AM
    J Consult Clin Psychol; 2018 Sep; 86(9):738-750. PubMed ID: 30138013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms.
    Hale AE; Ginsburg GS; Chan G; Kendall PC; McCracken JT; Sakolsky D; Birmaher B; Compton SN; Albano AM; Walkup JT
    J Clin Child Adolesc Psychol; 2018; 47(1):94-104. PubMed ID: 28278599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth.
    Cummings CM; Caporino NE; Settipani CA; Read KL; Compton SN; March J; Sherrill J; Piacentini J; McCracken J; Walkup JT; Ginsburg G; Albano AM; Rynn M; Birmaher B; Sakolsky D; Gosch E; Keeton C; Kendall PC
    J Consult Clin Psychol; 2013 Oct; 81(5):859-64. PubMed ID: 23750468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.